A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorlatinib Impurity 22 | CAS 1454851-42-3 - Request Quote

Picture of Lorlatinib Impurity 22

Lorlatinib Impurity 22

SZ CAT No:SZ-L054030
CAS No
1454851-42-3
Mol.F.
C31H42BFN2O9
Mol.Wt.
616.5
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorlatinib Impurity 22 is chemically . Lorlatinib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1454851-42-3

Purchase 1454851-42-3

Order 1454851-42-3

Enquire 1454851-42-3

price of 1454851-42-3

1454851-42-3 Supplier

1454851-42-3 Manufacturer

1454851-42-3 Exporter

buy high quality Lorlatinib Impurity 22

Purchase Lorlatinib Impurity 22

Lorlatinib Impurity 22 suppliers

Lorlatinib Impurity 22 manufacturers

Lorlatinib Impurity 22 price

Order Lorlatinib Impurity 22

Enquire Lorlatinib Impurity 22

Lorlatinib Impurity 22 cost

Lorlatinib Impurity 22 Supplier

Lorlatinib Impurity 22 Distributor

Lorlatinib Impurity 22 for Method Validation

Lorlatinib Reference Standard

Lorlatinib Impurity 22 for ANDA Filing

Lorlatinib Impurity 22 for Forced Degradation Studies

Lorlatinib Impurity 22 Identification Standards

Lorlatinib Impurity 22 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,